Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pill

Group 1 - Novo Nordisk shares experienced a rally on Friday despite a challenging week for the company [1] - The rally is attributed to the potential favorable decision from the Food and Drug Administration regarding a dispute over a copycat drug [1]